LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 7 of 483
Next
>>
>
151 to 175 of 12072 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	GSK1059615	0.04	uM	LJP5	1	E06	72	hr	1334	4201	3970	1.0579	1.0873
BT-20	GSK1059615	0.04	uM	LJP5	2	E06	72	hr	1334	4121	3970	1.0378	1.0569
BT-20	GSK1059615	0.04	uM	LJP5	3	E06	72	hr	1334	4116	3970	1.0365	1.0550
BT-20	GSK1059615	0.04	uM	LJP6	1	C06	72	hr	1334	3455	3970	0.8701	0.8043
BT-20	GSK1059615	0.04	uM	LJP6	2	C06	72	hr	1334	4266	3970	1.0743	1.1119
BT-20	GSK1059615	0.04	uM	LJP6	3	C06	72	hr	1334	3854	3970	0.9706	0.9557
BT-20	GSK1904529A	0.04	uM	LJP6	1	H24	72	hr	1334	3149	3970	0.7930	0.6882
BT-20	GSK1904529A	0.04	uM	LJP6	2	H24	72	hr	1334	3271	3970	0.8237	0.7345
BT-20	GSK1904529A	0.04	uM	LJP6	3	H24	72	hr	1334	3288	3970	0.8280	0.7410
BT-20	Omipalisib	0.04	uM	LJP6	1	N06	72	hr	1334	1212	3970	0.3052	-0.0465
BT-20	Omipalisib	0.04	uM	LJP6	2	N06	72	hr	1334	1167	3970	0.2939	-0.0636
BT-20	Omipalisib	0.04	uM	LJP6	3	N06	72	hr	1334	1159	3970	0.2919	-0.0666
BT-20	GSK 690693	0.04	uM	LJP5	1	F24	72	hr	1334	3208	3970	0.8079	0.7106
BT-20	GSK 690693	0.04	uM	LJP5	2	F24	72	hr	1334	3508	3970	0.8834	0.8244
BT-20	GSK 690693	0.04	uM	LJP5	3	F24	72	hr	1334	3640	3970	0.9167	0.8745
BT-20	GW843682X	0.04	uM	LJP6	1	B18	72	hr	1334	3523	3970	0.8872	0.8301
BT-20	GW843682X	0.04	uM	LJP6	2	B18	72	hr	1334	3785	3970	0.9532	0.9295
BT-20	GW843682X	0.04	uM	LJP6	3	B18	72	hr	1334	3454	3970	0.8698	0.8039
BT-20	HG-5-113-01	0.04	uM	LJP5	1	B12	72	hr	1334	3714	3970	0.9353	0.9026
BT-20	HG-5-113-01	0.04	uM	LJP5	2	B12	72	hr	1334	3806	3970	0.9585	0.9374
BT-20	HG-5-113-01	0.04	uM	LJP5	3	B12	72	hr	1334	3898	3970	0.9816	0.9723
BT-20	HG-5-88-01	0.04	uM	LJP6	1	A24	72	hr	1334	2671	3970	0.6726	0.5069
BT-20	HG-5-88-01	0.04	uM	LJP6	2	A24	72	hr	1334	3126	3970	0.7872	0.6795
BT-20	HG-5-88-01	0.04	uM	LJP6	3	A24	72	hr	1334	3013	3970	0.7588	0.6366
BT-20	Imatinib	0.04	uM	LJP6	1	N18	72	hr	1334	3352	3970	0.8441	0.7652

|<
<<
Previous
Page 7 of 483
Next
>>
>
151 to 175 of 12072 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)